StreetInsider.com News Articles

IMAX Corporation to Announce Third-Quarter 2026 Financial Results and Host Conference Call

Mon, 19 Oct 2026 16:05:00 -0400

NEW YORK--(BUSINESS WIRE)-- IMAX Corporation (NYSE: IMAX) today announced it will hold a conference call to discuss its third quarter 2026 financial results on Thursday, November 5th at 8:30 a.m. Eastern Time.

This call is being webcast and can be accessed at https://www.imax.com/content/investor-relations.

To access the call via telephone, interested parties will need to pre-register by going to the following link: https://register-conf.media-server.com/register/BIf4fcc885e18b4fce9844ecee1efeb2fb where you will be provided with a dial-in number and unique pin. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the

IMAX Corporation to Announce Third-Quarter 2026 Financial Results and Host Conference Call

Mon, 19 Oct 2026 16:05:00 -0400

This call is being webcast and can be accessed at https://www.imax.com/content/investor-relations.

IMAX Corporation (IMAX) PT Raised to $55 at Wells Fargo

Thu, 15 Oct 2026 05:08:02 -0400

Wells Fargo analyst Omar Mejias raised the price target on IMAX Corporation (NYSE: IMAX) to $55.00 (from $46.00) while maintaining a Overweight rating.

The analyst comments "Our 3Q AEBITDA goes from $52mm (45.2%) to $100mm (58.0%) as record GBO drives operating leverage. Investor focus now shifts to IMAX's ability to drive growth off of its '26 record results. Our PT goes to $55. Updating our IMAX GBO estimates. We're raising our 3Q IMAX GBO from $386mm to $712mm (+94% y/y) to reflect the record results, or nearly 2x its prior best qtr (2Q'19). The Odyssey led the way as IMAX's biggest

IMAX Corporation (IMAX) PT Raised to $55 at Wells Fargo

Thu, 15 Oct 2026 05:08:02 -0400

Wells Fargo analyst Omar Mejias raised the price target on IMAX Corporation (NYSE: IMAX) to $55.00 (from $46.00) while maintaining a Overweight rating.

IMAX Corporation (IMAX) stock decline on Infinity Vision news 'an absurd overreaction' - StoneX

Fri, 09 Oct 2026 09:35:42 -0400

StoneX analyst Mike Hickey reiterated a Buy rating and $65.00 price target on IMAX Corporation (NYSE: IMAX).

The analyst commented, "IMAX shares fell ~9.5% following the Infinity Vision headline, before ending the session ~3.8% below their level when the news was announced. We view this as an absurd overreaction to recycled news and a cheap marketing gimmick, particularly ahead of a 3Q that we expect to deliver record profitability. Disney originally announced Infinity Vision at CinemaCon in April; the incremental development is outreach to other studios. The underlying program certifies existing premium large format auditoriums based on screen, laser projection and

IMAX Corporation (IMAX) PT Raised to $64 at B.Riley

Thu, 08 Oct 2026 08:44:15 -0400

B.Riley analyst Drew Crum raised the price target on IMAX Corporation (NYSE: IMAX) to $64.00 (from $61.00) while maintaining a Buy rating.

IMAX Corporation (IMAX) PT Raised to $65 at StoneX on Strong Q4 Expectations

Wed, 07 Oct 2026 08:54:35 -0400

(Updated - October 7, 2026 8:54 AM EDT)

StoneX analyst Mike Hickey raised the price target on IMAX Corporation (NYSE: IMAX) to $65.00 (from $60.00) while maintaining a Buy rating.

The analyst commented, "IMAX’s growth story doesn’t end with The Odyssey: like Avatar, we believe this transformational event resets the platform’s earnings power and ignites a new cycle of market-share gains, filmmaker adoption and network expansion. We reiterate our Buy rating and raise our PT to $65 from $60, applying a 16x multiple to our 2027 AEBITDA estimate. We are raising our 3Q estimates again following IMAX’s record box office performance, forecasting

IMAX Corporation (IMAX) PT Raised to $65 at StoneX on Strong Q4 Expectations

Wed, 07 Oct 2026 08:54:35 -0400

(Updated - October 7, 2026 8:54 AM EDT)

StoneX analyst Mike Hickey raised the price target on IMAX Corporation (NYSE: IMAX) to $65.00 (from $60.00) while maintaining a Buy rating.

Form 4 IMAX CORP For: Sep 15 Filed by: Dolci Giovanni M.

Fri, 02 Oct 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20261002/27142138.html

Morgan Stanley Starts IMAX Corporation (IMAX) at Overweight

Thu, 24 Sep 2026 03:35:52 -0400

Morgan Stanley analyst Daniel Duran initiates coverage on IMAX Corporation (NYSE: IMAX) with a Overweight rating and a price target of $63.00.

The analyst comments: “We initiate coverage of IMAX shares with an Overweight rating and a $63 price target,~20% upside, based on ~17x EV/NTM EBITDA (MS-Defined, burdened by SBC & Film Amortization, see Exhibit 48) – largely in-line with the stock's current trading multiple. Our OW investment thesis is straightforward, MSD IMAX network/box office growth should translate to mid/high-teens EBITDA/FCF growth and drive equity appreciation (see Exhibit 4). We see the 3-points below as core to our thesis:

Global IMAX box

Morgan Stanley Starts IMAX Corporation (IMAX) at Overweight

Thu, 24 Sep 2026 03:35:52 -0400

Morgan Stanley analyst Daniel Duran initiates coverage on IMAX Corporation (NYSE: IMAX) with a Overweight rating and a price target of $63.00.

Global IMAX box

Hamilton ETFs Announces September 2026 Monthly, Quarterly & Upcoming Semi-Monthly Cash Distributions

Tue, 22 Sep 2026 20:00:00 -0400